Free Newsletter
SPOTLIGHT: More good news for Alzheimer's patients
Don't plan the party yet, but there's more good news for Alzheimer's patients and statin makers alike. New research that combined cognitive monitoring before death and brain dissection afterward shows that seniors who'd taken statin drugs to lower their cholesterol had developed fewer of the protein deposits in their brains that are the hallmarks of Alzheimer's Disease. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: